Publications 2013 - Fondation Asile des aveugles

Publications 2013
Revues scientifiques avec politique éditoriale
1. Abplanalp J., Laczko E., Philp N.J., Neidhardt J., Zuercher J., Braun P., Schorderet D.F., Munier F.L., Verrey F., Berger W.,
Camargo S.M., Kloeckener-Gruissem B. The cataract and glucosuria associated monocarboxylate transporter MCT12 is a new
creatine transporter. Hum Mol Genet. 2013;22:3218-3226.
2. Abouzeid H., Moetteli L., Munier F.L. New-generation multifocal intraocular lens for pediatric cataract. Ophthalmologica
2013;230:100-107.
3. Allaman-Pillet N., Oberson A., Munier F., Schorderet D.F. The Bcl-2/Bcl-XL inhibitor ABT-737 promotes death of retinoblastoma
cancer cells. Ophthalmic Genet. 2013;34:1-13.
4. Balmer D., Emery M., Andreux P., Auwerx J., Ginet V., Puyal J., Schorderet D.F., Roduit R. Autophagy defect is associated with
low glucose-induced apoptosis in 661W photoreceptor cells. PLoS One 2013;8:e74162.
5. Berguiga M., Mameletzi E., Nicolas M., Rivier D., Majo F. Long-term follow-up of multilayer amniotic membrane transplantation
(MLAMT) for non-traumatic corneal perforations or deep ulcers with Descemetocele. Klin Monbl Augenheilkd. 2013; 230:413-418.
6. Borruat F.X. Oculopalatal tremor : current concepts and new observations. Curr Opin Neurol. 2013;26:67-73.
7. Bousquet E., Beydoun T., Zhao M., Hassan L., Offret O., Behar-Cohen F. Mineralocorticoid receptor antagonism in the treatment
of chronic central serous chorioretinopathy : a pilot study. Retina 2013;33:2096-2102.
8. Boulling A., Wicht L., Schorderet D.F. Identification of HMX1 target genes : a predictive promoter model approach. Mol Vi.
2013;19:1779-1794.
9. Brodie S.E., Munier F.L., Francis J.H., Marr B., Gobin Y.P., Abramson D.H. Persistence of retinal function after intravitreal
melphalan injection for retinoblastoma. Doc Ophthalmol. 2013; 126:79-84.
10. Burkitt Wright E.M., Porter L.F., Spencer H.L., Clayton-Smith J., Au L., Munier F.L., Smithson S., Suri M., Rohrbach M., Manson
F.D., Black G.C. Brittle cornea syndrome : recognition, molecular diagnosis and management. Orphanet J Rare Dis. 2013;8:68.
11. Cachafeiro M., Bemelmans A.P., Samardzija M., Afanasieva T., Pournaras J.A., Grimm C., Kostic C., Philippe S., Wenzel A.,
Arsenijevic Y. Hyperactivation of retina by light in mice leads to photoreceptor cell death mediated by VEGF and retinal pigment
epithelium permeability. Cell Death Dis. 2013;4:e781.
12. Casparis H., Guex-Crosier Y., Wolfensberger T.J., Schalenbourg A. Peripheral serous pigment epithelial detachment and
retinal detachment presumably associated with hydrochlorothiazide use. Klin Monbl Augenheilkd. 2013; 230:437-439.
13. Clarke L.A., Guex-Crosier Y., Hofer M. Epidemiology of uveitis in children over a 10-year period. Clin Exp Rheumatol.
2013;31:633-637.
14. Cottet S., Jüttner R., Voirol N., Chambon P., Rathjen F.G., Schorderet D.F., Escher P. Retinal pigment epithelium protein of 65
kDA gene-linked retinal degeneration is not modulated by chicken acidic leucine-rich epidermal growth factor-like domain
containing brain protein/Neuroglycan C/ chondroitin sulfate proteoglycan 5. Mol Vis. 2013;19:2312-2320.
15. Da Silva G.R., Da Silva­Cunha A. Jr, Vieira L.C., Silva L.M., Ayres E., Oréfice R.L., Fialho S.L., Saliba J.B., Behar­Cohen F.
Montmorillonite clay based polyurethane nanocomposite as substrate for retinal pigment epithelial cell growth. J Mater Sci Mater
Med. 2013;24:1309-1317.
16. Dari M.L., Nguyen C., Wolfensberger T.J., Pournaras J.A. Systematic treatment of central retinal vein occlusion. Klin Monbl
Augenheilkd. 2013; 230:434-436.
17. Deli A., Moetteli L., Ambresin A., Mantel I. Comparison of fundus autofluorescence images acquired by the confocal scanning
laser ophthalmoscope (488 nm excitation) and the modified Topcon fundus camera (580 nm excitation). Int Ophthalmol.
2013;33:635-643.
18. El Sanharawi M., Touchard E., Benard R., Bigey P., Escriou V., Mehanna C., Naud M.C., Berdugo M., Jeanny J.C., Behar-Cohen
F. Long-term efficacy of ciliary muscle gene transfer of three sFlt-1 variants in a rat model of laser-induced choroidal
neovascularization. Gene Ther. 2013;20:1093-1103.
19. Eperon S., Rodriguez-Aller M., Balaskas K., Gurny R., Guex-Crosier Y. A new drug delivery system inhibits uveitis in an animal
model after cataract surgery. Int J Pharm. 2013;443:254-261.
20. Eperon S., Vaudaux J., Guex-Crosier Y. Experimental uveitis can be maintained in rabbits for a period of six weeks after a safe
sensitization method. Curr Eye Res. 2013;38:405-412.
21. Ferrini W., Ambresin A. Intravitreal dexamethasone implant for the treatment of macular edema after retinal vein occlusion in a
clinical setting. Klin Monbl Augenheilkd. 2013;230:423-426.
22. Ferrini W., Aubert V., Balmer A., Munier F.L., Abouzeid H. Anterior uveitis and cataract after rubella vaccination : a case report of
a 12-month-old girl. Pediatrics 2013;132:e1035-e1038.
23. Gkaragkani E., Nguyen C., Borruat, F.X. Acquired oscillopsia : potential complication after multifocal IOL implantation. JCRS
Online Case Reports 2013;1:e15-e16.
24. Guber I., Moetteli L., Magnin L., Majo F. Moving from a mechanical microkeratome to a femtosecond laser for LASIK to correct
astigmatic patients : clinical outcomes of a retrospective, consecutive, comparative study. Klin Monbl Augenheilkd. 2013;230:337341.
25. Guex-Crosier Y. Editorial : IgG4-related inflammatory disease - a new entity. Klin Monbl Augenheilkd. 2013;230:316.
26. Hamann S., Métrailler S., Schorderet D.F., Cottet S. Analysis of the cytoprotective role of α­crystallins in cell survival and
implication of the αA­crystallin C­terminal extension domain in preventing bax­induced apoptosis. PLoS One 2013;8:e55372.
27. Jang L., Borruat F.X. Teaching video neuroImages : micronystagmus of oculopalatal tremor. Neurology. 2013;80:e27.
28. Kaeser P.F., Brodsky M.C. Fourth cranial nerve palsy and Brown syndrome : two interrelated congenital cranial dysinnervation
disorders ? Curr Neurol Neurosci Rep. 2013;13:352.
29. Kardon R.H., Hong S., Kawasaki A. Entrance pupil size predicts retinal illumination in darkly pigmented eyes, but not lightly
pigmented eyes. Invest Ophthalmol Vis Sci. 2013;54:5559-5567.
30. Kermorvant-Duchemin E., Pinel A.C., Lavalette S., Lenne D., Raoul W., Calippe B., Behar-Cohen F., Sahel J.A., Guillonneau X.,
Sennlaub F. Neonatal hyperglycemia inhibits angiogenesis and induces inflammation and neuronal degeneration in the retina.
PLoS One 2013;8:e79545.
31. Kodjikian L., Souied E.H., Mimoun G., Mauget­Faÿsse M., Behar­Cohen F., Decullier E., Huot, L., Aulagner G. ; GEFAL Study
Group. Ranibizumab versus bevacizumab for neovascular age-related macular degeneration : results from the GEFAL
noninferiority randomized trial. Ophthalmology 2013;120:2300-2309.
32. Kostic C., Lillico S.G., Crippa S.V., Grandchamp N., Pilet H., Philippe S., Lu Z., King T.J., Mallet J., Sarkis C., Arsenijevic Y.,
Whitelaw C.B. Rapid cohort generation and analysis of disease spectrum of large animal model of cone dystrophy. PLoS One
2013;8:e71363.
33. Kowalczuk L., Latour G., Bourges J.L., Savoldelli M., Jeanny J.C., Plamann K., Schanne-Klein M.C., Behar-Cohen F. Multimodal
highlighting of structural abnormalities in diabetic rat and human corneas. Transl Vis Sci Technol. 2013;2:3.
34. Kuonen A., Vaudaux J., Hamedani M., Schuster V., Albisetti M., von der Weid N., Kaeser P.F. Ligneous conjunctivitis in a young
patient with homozygous K19E plasminogen gene mutation : a diagnostic and therapeutic challenge. Klin Monbl Augenheilkd.
2013;230:346-348.
35. Luder H.U., Gerth-Kahlert C., Ostertag-Benzinger S., Schorderet D.F. Dental phenotype in Jalili syndrome due to a c.1312
dupC homozygous mutation in the CNNM4 gene. PLoS One 2013;8:e78529.
36. Majo F., Nicolas M. Darwin or Lamarck ? Rôle des cellules souches épithéliales de la cornée et de leur micro­environnement
dans le traitement des destructions de la surface oculaire. Biol Aujourd'hui 2013;207:97-108.
37. Mantel I., Deli A., Iglesias K., Ambresin A. Prospective study evaluating the predictability of need for retreatment with intravitreal
ranibizumab for age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2013;251:697-704.
38. Métrailler S., Emery M., Schorderet D.F., Cottet S., Roduit R. ERK1/2 pathway is activated in degenerated Rpe65­deficient mice.
Exp Eye Res. 2013;116C:86-95.
39. Moulin A., Védy D., Guex­Crosier Y., Zografos L., Schalenbourg A. Conjunctival extrascleral extension of a myeloid sarcoma : a
clinicopathological case report. Klin Monbl Augenheilkd. 2013;230:443-444.
40. Munier F.L., Gaillard M.C., Balmer A., Beck-Popovic M. Intravitreal chemotherapy for vitreous seeding in retinoblastoma : recent
advances and perspectives. Saudi J Ophthalmol 2013;27:147-150.
41. Omri S., Behar­Cohen F., Rothschild P.R., Gélizé E., Jonet L., Jeanny J.C., Omri B., Crisanti P. PKCζ mediates breakdown of
outer blood-retinal barriers in diabetic retinopathy. PLoS One 2013;8:e81600.
42. Page L., Polok B., Bustamante M., Schorderet D.F. Bigh3 is upregulated in regenerating zebrafish fin. Zebrafish 2013;10:3642.
43. Petropoulos I.K., Pournaras J.A., Stangos A.N., Pournaras C.J. Preretinal partial pressure of oxygen gradients before and after
experimental pars plana vitrectomy. Retina 2013;33:170-178.
44. Pilly B., Heath G., Tschuor P., Lightman S., Gale R.P. Overview and recent developments in the medical management of
paediatric uveitis. Expert Opin Pharmacother. 2013;14:1787-1795.
45. Pipparelli A., Arsenijevic Y., Thuret G., Gain P., Nicolas M., Majo F. ROCK inhibitor enhances adhesion and wound healing of
human corneal endothelial cells. PLoS One 2013;8:e62095.
46. Rodriguez-Aller M., Guillarme D., El Sanharawi M., Behar-Cohen F., Veuthey J.L., Gurny R. In vivo distribution and ex vivo
permeation of cyclosporine A prodrug aqueous formulations for ocular application. J Control Release 2013;170:153-159.
47. Schalenbourg A., Zografos L. Pitfalls in colour photography of choroidal tumours. Eye 2013;27:224-229.
48. Sennlaub F., Auvynet C., Calippe B., Lavalette S., Poupel L., Hu S.J., Dominguez E., Camelo S., Levy O., Guyon E., Saederup
N., Charo I.F., Rooijen N.V., Nandrot E., Bourges J.L., Behar-Cohen F., Sahel J.A., Guillonneau X., Raoul W., Combadiere C.
CCR2(+) monocytes infiltrate atrophic lesions in age-related macular disease and mediate photoreceptor degeneration in
experimental subretinal inflammation in Cx3cr1 deficient mice. EMBO Mol Med. 2013;5:1775-1793.
49. Shetye N.G., Mataftsi A., Maeder P., Moulin A.P., Gaillard M.C., Balmer A., Popovic M.B., Munier F.L. Post-chemoreduction cryptic
optic nerve relapse in a patient with bilateral retinoblastoma. Br J Ophthalmol. 2013; 97:233-246.
50. Simó R., Roy S., Behar­Cohen F., Keech A., Mitchell P., Wong T.Y. Fenofibrate : a new treatment for diabetic retinopathy.
Molecular mechanisms and future perspectives. Curr Med Chem. 2013;20:3258-3266. 51. Strupp M., Borruat F.X. Editorial. Curr
Opin Neurol. 2013;26:43-44.
52. Thommen F., Hewer E., Schäfer S.C., Vassella E., Kappeler A., Vajtai I. Rosette­forming glioneuronal tumor of the cerebellum
in statu nascendi: an incidentally detected diminutive example indicates derivation from the internal granule cell layer. Clin
Neuropathol. 2013;32:370-376.
53. Tiab L., Largueche L., Chouchane I., Derouiche K., Munier F.L., El Matri L., Schorderet D.F. A novel homozygous R764H
mutation in crumbs homolog 1 causes autosomal recessive retinitis pigmentosa. Mol Vis. 2013;19:829-834.
54. Tran B.K., Schalenbourg A., Bovey E., Zografos L., Wolfensberger T.J. Role of vitreoretinal surgery in maximizing treatment
outcome following complications after proton therapy for uveal melanoma. Retina 2013;33:1777-1783.
55. Tschuor P., Pilly B., Venugopal D., Gale R.P. Optimising assessment intervals improves visual outcomes in ranibizumabtreated age-related neovascular degeneration : using the stability phase as a benchmark. Graefes Arch Clin Exp Ophthalmol.
2013;251:2327-2330.
56. Vaclavik V., Borruat F.X., Ambresin A., Munier F.L. Novel maculopathy in patients with spinocerebellar ataxia type 1
autofluorescence findings and functional characteristics. JAMA Ophthalmol. 2013;131:536-538.
57. Varsori M., Sharkawi E. Giant cell arteritis causing retinal and posterior carotid circulation strokes. Klin Monbl Augenheilkd.
2013;230:374-375.
58. Voide N., Borruat F.X. Isolated Horner syndrome and orbital hemangioma. Klin Monbl Augenheilkd. 2013;230: 365-366.
59. Wimmersberger Y., Bergin C., Sharkawi E. Reattachment of Descemet's membrane using C3F8 gas in an eye with a
Baerveldt aqueous shunt. Klin Monbl Augenheilkd. 2013;230: 363-364.
60. Yahyavi M., Abouzeid H., Gawdat G., de Preux A.S., Xiao T., Bardakjian T., Schneider A., Choi A., Jorgenson E., Baier H., El
Sada M., Schorderet D.F., Slavotinek A.M. ALDH1A3 loss of function causes bilateral anophthalmia/microphthalmia and
hypoplasia of the optic nerve and optic chiasm. Hum Mol Genet. 2013;22:3250-3258.
61. Zencak D., Schouwey K., Chen D., Ekström P., Tanger E., Bremner R., van Lohuizen M., Arsenijevic Y. Retinal degeneration
depends on Bmi1 function and reactivation of cell cycle proteins. Proc Natl Acad Sci USA. 2013;110:E593-E601.
Chapitres de livres, livres, revues et lettres
1. Audren F., Bok-Beaube C., Costet C., Denis D., Kaeser P.F., Klainguti G., Oger-Lavenant F., Sauer A., Speeg-Schatz C., Zanin E.
Désordres oculomoteurs neurogènes et myogènes. In : Péchereau A. (Ed.) Strabisme. Rapport de la Société Française
d'Ophtalmologie. Paris : Elsevier Masson, cop. 2013, pp. 245-289.
2. Borruat F.X. Posterior cortical atrophy : review of the recent literature. Curr Neurol Neurosci Rep.2013;13:406-413.
3. Egan R.A., Kawasaki, A. Tadpole pupil. Neurology. 2013;80:1068 (Comment and answer).
4. Friedman D.I., Kawasaki A. Tadpole pupil. Neurology. 2013;81:1724 (Letter)
5. Hamédani M., Obéric A. Orbitopathie dysthyroïdienne : du diagnostic au traitement. Rev Med Suisse 2013;9, No 368:66­71.
6. Klainguti G., Kaeser P.F. Paralysies du nerf trochléaire (IV). In : Péchereau A., Speeg­Schatz C., Denis D. Strabisme. Rapport de
la Société Française d'Ophtalmologie. Paris : Masson, cop 2013, pp 254­259.
7. Matet A., Wolff B., Vasseur V., Mauget­Faÿsse M. Apport de l'OCT spectral domain dans les syndromes des taches blanches.
Cahiers d'Ophtalmologie, N°170, 2013.
8. Mauget­Faÿsse M., Wolff B., Basdekidou C., Matet A., Vasseur V., Pâques M., Sahel J.A. En face optical coherence tomography
in idiopathic macular telangiectasia. In : Lumbroso B., Huang D., Romano A., Rispoli M., Coscas G. (Eds). Clinical En Face OCT
Atlas. New Delhi :
Jaypee-Highlights, 2013.
9. Münch M., Kawasaki A. Intrinsically photosensitive retinal ganglion cells : classification, function and clinical implications. Curr
Opin Neurol. 2013;26:45-51.
10. Papadopoulou D., Mangioris G., Zografos L. Tumeurs de l'iris et du corps ciliaire. Classification et approche diagnostic et
thérapeutique. Mise au point. Bulletin Numérique du 46ème Congrès panhellénique d'ophtalmologie 23­26.5.2013. Costa
Navarino-Messinia,
Grèce.
11. Venturini G., Moulin A. PTEN Involvement in eye embryology and pathology. In : Ke Xu (Ed.) PTEN: Structure, Mechanisms-ofAction, Role in Cell Signaling and Regulation. Hauppauge NY : Nova Science Publishers, 2013, chap 7.
12. Wolff B., Matet A., Vasseur V., Sahel J.A., Mauget­Faÿsse M. B­scan and 'En­Face' spectraldomain optical coherence
tomography imaging for the diagnosis and follow-up of white dot syndromes. In : Kawasaki M. (Ed.). Optical Coherence
Tomography. Rijeka : InTech, 2013, chapter 2.
13. Wolff B., Matet A., Vasseur V., Sahel J.A., Mauget­Faÿsse M. Outer retinal tubulations. In : Lumbroso B., Huang D., Romano A.,
Rispoli M., Coscas G. (Eds). Clinical En Face OCT Atlas. New Delhi : Jaypee-Highlights, 2013.
14. Zografos L. Editorial. In : Tritar El Matri, L. (Ed.) : Les Hérédodégénérescences Chorio­Rétiniennes. Rapport de la Société
Tunisienne d'Ophtalmologie 2013, p. 9.
15. Zografos L. Préface. In : Dictionnaire de la Terminologie Ophtalmologique Anglais­Grec / Grec Anglais. Edip. P.K. Oikonomidi,
L.P. Lambrogiannis. Thessaloniki : University Studio Press, 2013, pp. 9-10.
Autres publications
1. Abouzeid H. Femtolaser dans la chirurgie de la cataracte : un avenir prometteur. Ophta 2013, No 4, 254-256 ; Rev Med Suisse
9(2013), No 410, 2350-2353.
2. Abouzeid H. Multifokale Intraokularlinsen : ein Überblick. Ophta 2013, No 2, 107­113.
3. Abouzeid H. Une revue des lentilles intraoculaires multifocales. Ophta 2013, No 1, 11-18.
4. Boughton B., Chévez­Barrios P., Gombos D.S., Munier F.L., Shields C. Intravitreal chemotherapy for retinoblastoma : promising
but controversial. EyeNet Magazine, September 2013:31-33.
5. Guttman Krader C., Shields C., Munier F. Retinoblastoma outcomes : modern approaches deliver benefits of localized
chemotherapy with strategies to minimise risk. Eurotimes 2013;18:32.
6. Hubbard G.B., Engelbrecht N.E., Munier F.L. Intravitreal chemotherapy : new treatment for retinoblastoma seeding. Retina
Times 2013;31:44-47.
7. Kawasaki A. Selective wavelength pupillometry to evaluate outer and inner retinal photoreception. Umea University Print and
Media, Umea, Sweden 2013 (thesis monograph).
8. Majo F. Le meeting de l'European Eye Bank Association à Lausanne, 24 et 25 janvier 2014. Ophta 2013, No 5, 350­351.
9. Thomas F., Abouzeid H. MIOL implantation in paediatric cases. Ophthalmology Times. May 2013.
10. Wolfensberger T. « Dadurch werden Blinde unabhängig ». 20 Minuten, 6 März 2013.
11. Wolfensberger T. «Et les aveugles verront…». Migros Magazine, Février 2013, No 7 : 20­25 .
12. Wolfensberger T. Le premier oeil bionique de Suisse sera greffé à Lausanne. 24 Heures, 30 avril 2013, pp. 1 et 17.
Abstracts
1. Abou Zeid H., Ferrini W. Courbe d'apprentissage et complications de la chirurgie de la cataracte par laser femtoseconde.
Ophta 2013, S56. 2. Abou Zeid H., Ferrini W. Learning curve and complications of first cases of femtosecond
laser cataract surgery. European Society of Cataract and Refractive Surgeons Meeting (ESCRS), 2013, Amsterdam, FP-3671.
3. Bela C., Klainguti G. Insertion anormale des muscles oculomoteurs dans le syndrome de Williams Beuren (WBS). Ophta
2013, S85.
4. Bela C., Moulin A., Obéric A., Hamédani M. Association entre papillomes oculopalpébraux dysplasiques et présence de Human
Papilloma Virus (HPV). Ophta 2013, S52.
5. Brockhaus L., Zinkernagel M., Schalenbourg A., Moulin A., Zografos L. Case report : Leiomyom der posterioren Choroidea.
Ophta 2013, S90.
6. Casparis H., Mantel I., Wolfensberger T., Becker M., Eich G., Graf N., Michels S. Inzidenz von vermuteten Endophthalmitis nach
intravitrealen Injektionen im Operationssaal : retrospektive Multizenterstudie. Ophta 2013, S54.
7. El Wardani M., Bergin C., Sharkawi E. Révision chirurgicale précoce de la formation de bulle kystique post trabéculectomie.
Ophta 2013, S81.
8. Fracheboud S., Vaudaux J., Clarke L., Guex­Crosier Y., Hofer M. Analyse rétrospective des complications systémiques des
traitements immunosuppresseurs lors d'uvéites pédiatriques. Ophta 2013, S55.
9. Gaillard M., Balmer A., Hughton S., Munier F. Melphalan intra­vitréen dans le rétinoblastome avec essaimage vitréen dense.
Ophta 2013, S46.
10. Gaillard M.C., Houghton S., Balmer A., Beck­Popovic M., Munier F.L. Les nouvelles voies de chimiothérapie dans le
rétinoblastome. 119ème Congrès de la Société Française d'Ophtalmologie, Paris, 2013.
11. Gaillard M., Munier F., Schalenbourg A., Fleisch B. Rétinome révélé par des myodésopsies. Ophta 2013, S91.
12. Garcia-Arumi J., Damato B., Desjardins L., Schalenbourg A., Zografos L. Debate : Challenging cases of retinal pigment
epithelium lesions : how to diagnose ? how to manage ? EVER European Association for Vision and Eye Research. Acta
Ophthalmol 91(2013), Suppl 252.
13. Gianniou C., Mantel I., Spertini F., Besse Hayat C., Ambresin A. Réaction d'hypersensibilité de type retard secondaire aux
injections intravitréennes d'anti­VEGFmAb : à propos de trois cas. Ophta 2013, S96.
14. Gianniou C., Marchionno L., Decugis D., Ambresin A., Mantel I. Outer retinal tubulation (ORT) in neovascular AMD treated with
ranibizumab. Euretina September 2013, Hamburg.
15. Hashemi K., Guber I., Majo F. Variabilité des paramètres mesurés avec le Pentacam HR dans le dépistage des kératocônes
débutants à modérés. Ophta 2013, S73.
16. Hoeckele N., Kaeser P.F., Klainguti G. Results after tucking the anterior portion of the superior oblique muscle. 36th Meeting of
the European Strabismological Association, Septembre 2013, Nice.
17. Jakobsson C., Schorderet D., Othman I., Sabry S., Munier F., Abou Zeid H. Nouvelle mutation homozygote RPE65 dans
l'amaurose congénitale de Leber (LCA) associée à une dystrophie cône­bâtonnet. Ophta 2013, S104.
18. Jang L., Gianniou C., Ambresin A., Mantel I. Le liquide sous rétinien persistant dans la DMLA exsudative traitée avec
ranibizumab intravitréen : le résultat fonctionnel. Ophta 2013, S101.
19. Kaeser P.F., Hoeckele N., Klainguti G. Results of Kestenbaum operation in congenital nystagmus with face turn. 36th Meeting
of the European Strabismological Association, Septembre 2013, Nice.
20. Khafagy M.M., Schorderet D.F., Abouzeid H. A novel COL2A1 nonsense mutation causes Stickler syndrome type I. ARVO 2013
Annual Meeting, abstract 1338 - A0032.
21. Klainguti G., Hoeckele N., Kaeser P. Ergebnisse nach Kestenbaum­Operation bei frühkindlichem idiopathischen
Fixationsnystagmus. Ophta 2013, S54.
22. Kloeckener-Gruissem B., Philp N., Abplanalp J., Camargo S., Schorderet D., Munier F., Neidhardt J., Verrey F., Laczko E,
Berger W. Identification of the substrate and characterization of transport properties for the cataract associated monocarboxylate
transporter MCT12. ARVO 2013 Annual Meeting, abstract 3683.
23. Madal P., Pournaras J., Wolfensberger T. 27G Vitrektomie für Glaskörper­Trübungen. Ophta 2013, S103.
24. Majo F. Stem cells in the central cornea : to be or not to be? EVER European Association for Vision and Eye Research. Acta
Ophthalmol 91(2013), Suppl 252.
25. Mantel I., Gianniou C., Marchionno L., Decugis D., Ambresin A. Tubulation rétinienne externe dans la DMLA exsudative traitée
par ranibizumab. Ophta 2013, S46.
26. Mantel I., Gianniou C., Niderprim S., Ambresin A. «Observe and plan» regimen : prediction of individual need for retreatment
with ranibizumab in neovascular AMD. Euretina September 2013, Hamburg.
27. Matet A., Fardeau C., Terrada C., Cassoux N., Paris L., Le Hoang P., Bodaghi B. Récidives de rétino­choroïdite toxoplasmique
: à propos de 40 cas prouvés par analyse de l'humeur aqueuse. 119ème Congrès de la Société Française d'Ophtalmologie,
Paris, 2013.
28. Matet A., Fardeau C., Terrada C., Cassous N., Paris L., LeHoang P., Bodaghi B. Recurrence of toxoplasmic retinochoroiditis :
analysis of cases proven by initial analysis of aqueous humor. European Association for Vision and Eye Research (EVER), Nice,
2013.
29. Mayer C., Hamédani M. Mycose palpébrale : quand y penser ? Ophta 2013, S50. 30. Mayer C., Wolfensberger T., Pournaras J.
Anti­VEGF et rétinopathie diabétique proliférative : à quoi s'attendre ? Ophta 2013, S97.
31. Moulin A. RPE adenocarcinoma arising in a congenital RPE hypertrophy. European Ophthamic Pathology Society (EOPS), 57.6.2013, Copenhagen.
32. Moulin A., Nicolas M. E3746 - miRNA and conjunctival melanoma migration. EVER European Association for Vision and Eye
Research. Acta Ophthalmol 91(2013), Suppl 252.
33. Moulin A., Wolfensberger T., Zografos L., Schalenbourg A. Adénocarcinome de l'épithélium pigmentaire développé sur une
hypertrophie congénitale de l'épithélium pigmentaire traité par protons. Ophta 2013, S45.
34. Munier F.L., Gaillard M.C., Balmer A., Beck-Popovic M. Intravitreal chemotherapy : indications and results. European
Association for Vision and Eye Research (EVER), Nice, 2013.
35. Munier F., Gaillard M.C., Balmer A., Beck-Popovic M. Intravitreal melphalan eradicates vitreous disease in retinoblastoma
without causing tumor spread or significant retinal toxicity. XVIth Biennal Meeting of the International Society of Ocular Oncology.
Cleveland, 2013.
36. Nicolas M.J., Pipparelli A., Arsenijevic Y., Thuret G., Gain P., Majo F. ROCK inhibitor enhances adhesion and wound healing on
human corneal endothelial cells. ARVO 2013 Annual Meeting, abstract 1688 - D0323.
37. Niderprim S., Ambresin A., Deli A., Mantel I. Un régime de traitement : Observe and Plan, utilisant le ranibizumab pour la DMLA
exsudative. Impacts cliniques et économiques. Ophta 2013, S98.
38. Niderprim S., Ambresin A., Mantel I., Guex­Crosier Y., von Scheven A., Hofer M. Membrane néovasculaire inflammatoire traitée
par anti­VEGF intravitréen chez 2 enfants. S105.
39. Passarin O., Guex­Crosier Y., Reymond S., Michel A., Ghika J. Névrite optique associée à une rétinite paranéoplasique
autoimmune révélant un carcinome pulmonaire à petites cellules. Ophta 2013, S105.
40. Passarin O., Munier F.L., Tran V.T., Schorderet D.F., Vaclavik V. A novel heterozygote E2331* mutation in PRPF8 gene causes
a severe phenotype of retinitis pigmentosa with early loss of visual acuity. ARVO 2013 Annual Meeting, abstract 690 - D0212.
41. Passarin O., Vaudaux J., Guex­Crosier Y. Rétinite à CMV dans un contexte de pathologie onco­hématologique. Ophta 2013,
S55.
42. Pournaras J.A. ILM peeling or not : the best dye. EVER European Association for Vision and Eye Research. Acta Ophthalmol
91(2013), Suppl 252.
43. Pournaras J.A. Natural history of vitreoretinal interface disorders. EVER European Association for Vision and Eye Research.
Acta Ophthalmol 91(2013), Suppl 252.
44. Thommen F., Wolfensberger T., Gallaire F., Psaltis D. Modifizierte Mc Cannel Iridoplastie als Ersatz einer basalen Iridektomie
für Silikonöl­Tamponade bei Aphakie und partielle Aniridie. Ophta 2013, S104.
45. Tran H.V., Munier F.L. Dépôts de cristaux lenticulaires dans la dystrophie cristalline cornéo­rétinienne de Bietti. Société de
Génétique Ophtalmologique Francophone (SGOF), Montpellier, 2013.
46. Tran H.V., Vaclavik V., Schorderet D.F., Munier F.L. Dépôts de cristaux dans le cortex antérieur du cristallin dans la dystrophie
cristalline cornéo­rétinienne de Bietti. 119ème Congrès de la Société Française d'Ophtalmologie, Paris, 2013.
47. Vaclavic V., Munier F.L. Mutation dans un nouveau gène causant une dystrophie des cônes et une ciliopathie dans une famille
consanguine suisse. Société de Génétique Ophtalmologique Francophone (SGOF), Montpellier, 013.
48. Vaclavik V., Munier F.L., Schorderet D.F., Tran V.T. Crystal deposits in the anterior lens cortex in Bietti crystalline corneoretinal
dystrophy and first report of choroidal neovascular membrane in patient affected with Bietti. ARVO 2013 Annual Meeting, abstract
1350 - A0044.
49. Vaudaux J., Curchod M., Guex­Crosier Y. Détection de taches tardives persistantes par HRA et SD­OCT dans le MEWDS.
Ophta 2013, S106.
50. Vila J., de Massougnes S., Kawasaki A. Détermination de la variation du test­et­retest du 28­Hue de Roth. Ophta 2013, S87.
51. Voide N., Klainguti G., Presset C., Kaeser P. Esotropie circadienne : la chirurgie est­elle toujours indiquée ? Ophta 2013, S83.
52. Voide N., Klainguti G., Presset C., Kaeser P.F. Circadian esotropia : is surgery always the best treatment ? 36th Meeting of the
European Strabismological Association, Septembre 2013, Nice.
53. Voruz F., Kawasaki A. Réponse différentielle à la lumière liée à la structure de l'iris. Ophta 2013, S87.
54. Wolfensberger T. Irisrekonstruktion zum Schutz des cornealen Endothels bei Aniridie mit Silikonöl­Tamponade. Ophta 2013,
S50.
55. Wolfensberger T.J. Mechanism of fluid accumulation. EVER European Association for Vision and Eye Research. Acta
Ophthalmol 91(2013), Suppl 252.
56. Wolfensberger T.J. Surgical management of vitreoretinal interface disorders. EVER European Association for Vision and Eye
Research. Acta Ophthalmol 91(2013), Suppl 252.
57. Zografos L. Congenital hypertrophy of the retinal pigment epithelium (RPE). EVER European Association for Vision and Eye
Research. Acta Ophthalmol 91(2013), Suppl 252.
58. Zografos L., Schalenbourg A., Mantel I. Preventing neovascular glaucoma in uveal melanoma with ischemic retinal
detachment by associating anti-VEGFs to proton therapy.
36th Annual Macula Society Meeting, St. Regis, Monarch Beach, California, US, 27.2- 2.3 2013.
Fondation Asile des aveugles ­ Avenue de France 15 ­ Case Postale 133 ­ 1000 Lausanne 7 ­ Tél.: 021 626 81 11 ­ Fax: 021 626 80 15 ­ Dons: CCP 10­2707­0